Pulmonary Embolism: Mechanism and Therapeutic Innovation

NCT05360992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-05-04

No results posted yet for this study

Summary

To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).

Conditions

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Lu Hua, Dr. · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-10-13
Completion
2021-10-13

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05360992 on ClinicalTrials.gov